Affinity adsorption of glucose degradation products improves the biocompatibility of conventional peritoneal dialysis fluid.

BACKGROUND Reactive carbonyl compounds (RCOs) present in peritoneal dialysis (PD) fluid have been incriminated in the progressive deterioration of the peritoneal membrane in long-term PD patients. They are initially present in fresh conventional heat-sterilized glucose PD fluid and are supplemented during dwell time by the diffusion of blood RCOs within the peritoneal cavity. In the present study, RCO entrapping agents were immobilized on affinity beads to adsorb RCOs both in fresh PD fluid and in PD effluent. METHODS The RCO trapping potential of various compounds was assessed in vitro first by dissolving them in the tested fluid and subsequently after coupling with either epoxy- or amino-beads. The tested fluids include fresh heat-sterilized glucose and non-glucose PD fluids, and PD effluent. Their RCOs contents, that is, glyoxal (GO), methylglyoxal (MGO), 3-deoxyglucosone (3-DG), formaldehyde, 5-hydroxymethylfuraldehyde, acetaldehyde, and 2-furaldehyde were monitored by reverse-phase high-pressure liquid chromatography. The biocompatibility of PD fluid was assessed by a cytotoxic assay with either human epidermoid cell line A431 cells or with primary cultured human peritoneal mesothelial cells. RESULTS Among the tested RCO entrapping agents, hydrazine coupled to epoxy-beads proved the most efficient. It lowered the concentrations of three dicarbonyl compounds (GO, MGO, and 3-DG) and those of aldehydes present in fresh heat-sterilized glucose PD fluid toward the low levels observed in filter-sterilized glucose PD fluid. It did not change the glucose and electrolytes concentration of the PD fluid but raised its pH from 5.2 to 5.9. Hydrazine-coupled epoxy-bead also lowered the PD effluent content of total RCOs, measured by the 2,4-dinitrophenylhydrazone (DNPH) method. The cytotoxicity of heat-sterilized PD fluid incubated with hydrazine-coupled epoxy-beads was decreased to the level observed in filter-sterilized PD fluid as the result of the raised pH and the lowered RCOs levels. CONCLUSION Hydrazine-coupled epoxy-beads reduce the levels of a variety of dicarbonyls and aldehydes present in heat-sterilized glucose PD fluid to those in filter-sterilized PD fluid, without altering glucose, lactate, and electrolytes contents but with a rise in pH. Incubated with PD effluents, it is equally effective in reducing the levels of serum-derived RCOs. RCO entrapping agents immobilized on affinity beads improve in vitro the biocompatibility of conventional heat-sterilized glucose PD fluid. Their clinical applicability requires further studies.

[1]  O. Devuyst,et al.  Toward better dialysis compatibility: advances in the biochemistry and pathophysiology of the peritoneal membranes. , 2002, Kidney international.

[2]  Geraint T. Williams,et al.  Morphologic changes in the peritoneal membrane of patients with renal disease. , 2002, Journal of the American Society of Nephrology : JASN.

[3]  Jenq-Wen Huang,et al.  Dipyridamole inhibits TGF-beta-induced collagen gene expression in human peritoneal mesothelial cells. , 2001, Kidney international.

[4]  O. Devuyst,et al.  Chronic uremia induces permeability changes, increased nitric oxide synthase expression, and structural modifications in the peritoneum. , 2001, Journal of the American Society of Nephrology : JASN.

[5]  A. Christensson,et al.  Long-term clinical effects of a peritoneal dialysis fluid with less glucose degradation products. , 2001, Kidney international.

[6]  B. Lindholm,et al.  Biocompatibility of New Peritoneal Dialysis Solutions: Clinical Experience , 2000, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[7]  T. Miyata,et al.  Effect of dwell time on carbonyl stress using icodextrin and amino acid peritoneal dialysis fluids. , 2000, Kidney international.

[8]  M. Pischetsrieder,et al.  First In Vitro and In Vivo Experiences with Stay·Safe Balance, A pH-Neutral Solution in a Dual-Chambered Bag , 2000, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[9]  T. Miyata,et al.  Mechanism of the inhibitory effect of OPB-9195 [(+/-)-2-isopropylidenehydrazono-4-oxo-thiazolidin-5-yla cetanilide] on advanced glycation end product and advanced lipoxidation end product formation. , 2000, Journal of the American Society of Nephrology : JASN.

[10]  T. Miyata,et al.  Advanced glycation and lipidoxidation of the peritoneal membrane: respective roles of serum and peritoneal fluid reactive carbonyl compounds. , 2000, Kidney international.

[11]  U. Frei,et al.  Effect of glucose degradation products on human peritoneal mesothelial cell function. , 2000, Journal of the American Society of Nephrology : JASN.

[12]  M. Lagarde,et al.  Reaction of metformin with dicarbonyl compounds. Possible implication in the inhibition of advanced glycation end product formation. , 1999, Biochemical pharmacology.

[13]  Y. Kawaguchi,et al.  Suppression of Nε-(Carboxymethyl)Lysine Generation by the Antioxidant N-Acetylcysteine , 1999 .

[14]  K. Tatsumi,et al.  2‐Isopropylidenehydrazono‐4‐oxo‐thiazolidin‐5‐ylacetanilide (OPB‐9195) treatment inhibits the development of intimal thickening after balloon injury of rat carotid artery: role of glycoxidation and lipoxidation reactions in vascular tissue damage , 1999, FEBS letters.

[15]  T. Hamamoto,et al.  A water-soluble tetrazolium salt useful for colorimetric cell viability assay , 1999 .

[16]  R. Krediet The peritoneal membrane in chronic peritoneal dialysis. , 1999, Kidney international.

[17]  M. Jadoul,et al.  Accumulation of carbonyls accelerates the formation of pentosidine, an advanced glycation end product: carbonyl stress in uremia. , 1998, Journal of the American Society of Nephrology : JASN.

[18]  J. Passlick–Deetjen,et al.  Randomized long-term evaluation of bicarbonate-buffered CAPD solution. , 1998, Kidney international.

[19]  H. Ferguson,et al.  Plasma proteins of rainbow trout (Oncorhynchus mykiss) isolated by binding to lipopolysaccharide from Aeromonas salmonicida. , 1998, Comparative biochemistry and physiology. Part B, Biochemistry & molecular biology.

[20]  T. Taguchi,et al.  In vivo formation of a Schiff base of aminoguanidine with pyridoxal phosphate. , 1998, Biochemical pharmacology.

[21]  John D. Williams,et al.  Peritoneal Dialysis Solution Biocompatibility: Inhibitory Mechanisms and Recent Studies with Bicarbonate-Buffered Solutions , 1997, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[22]  R. Krediet,et al.  Icodextrin'S Effects on Peritoneal Transport , 1997, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[23]  T. Shigematsu,et al.  Immunohistochemical detection of advanced glycosylation end-products in the peritoneum and its possible pathophysiological role in CAPD. , 1997, Kidney international.

[24]  N. Topley In vitro biocompatibility of bicarbonate-based peritoneal dialysis solutions. , 1997, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[25]  B. Faller Amino acid-based peritoneal dialysis solutions. , 1996, Kidney international. Supplement.

[26]  A. Wieslander,et al.  Cytotoxicity, pH, and glucose degradation products in four different brands of PD fluid. , 1996, Advances in peritoneal dialysis. Conference on Peritoneal Dialysis.

[27]  Paul J Thornalley,et al.  Binding and modification of proteins by methylglyoxal under physiological conditions. A kinetic and mechanistic study with N alpha-acetylarginine, N alpha-acetylcysteine, and N alpha-acetyllysine, and bovine serum albumin. , 1994, The Journal of biological chemistry.

[28]  T. Agishi,et al.  Development of continuous recirculating peritoneal dialysis using a double lumen catheter. , 1992, ASAIO journal.

[29]  T. Hanawa,et al.  Purification and reconstitution of mu-opioid receptors in liposome. , 1992, Journal of chromatography.

[30]  A. Cerami,et al.  Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking. , 1986, Science.

[31]  J. H. Schwartz,et al.  Immunological characterization of an anti-actin antibody specific for cytoplasmic actins and its use for the immunocytological localization of actin in Aplysia nervous tissue. , 1983, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[32]  D. Tarbell,et al.  New Method to Prepare N-t-Butoxycarbonyl Derivatives and the Corresponding Sulfur Analogs from di-t-Butyl Dicarbonate or di-t-Butyl Dithiol Dicarbonates and Amino Acids. , 1972, Proceedings of the National Academy of Sciences of the United States of America.

[33]  H. Dintzis,et al.  The derivatization of cross-linked polyacrylamide beads. Controlled introduction of functional groups for the preparation of special-purpose, biochemical adsorbents. , 1969, Biochemistry.